To the best of our knowledge, this is the first study to evaluate the combined prognostic potential of tumor-infiltrating MDSCs and PD-1/PD-L1 axis in patients with locally advanced rectal cancer treated with neoadjuvant CRT. The gene discussed is PDCD1; the disease is rectal cancer.